These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Search MEDLINE/PubMed

  • Title: Assessing coronary artery disease with dipyridamole technetium-99m-tetrofosmin SPECT: a multicenter trial.
    Author: He ZX, Iskandrian AS, Gupta NC, Verani MS.
    Journal: J Nucl Med; 1997 Jan; 38(1):44-8. PubMed ID: 8998148.
    Abstract:
    UNLABELLED: Exercise 99mTc-tetrofosmin myocardial scintigraphy is as accurate as exercise 201TI imaging. Thus far, no data are available on tetrofosmin imaging during pharmacologic stress. We evaluated the feasibility of using. 99mTc-tetrofosmin myocardial SPECT during vasodilation with dipyridamole for detecting coronary artery disease. METHODS: Sixty-four patients, enrolled in three centers in the U.S., underwent one-day dipyridamole/rest tetrofosmin SPECT. Coronary angiography, performed in 59 patients within 2 mo of the SPECT study, revealed normal coronary arteries or insignificant coronary stenosis in 11 patients and significant (> or = 50% luminal diameter stenosis) coronary stenoses in 48 patients. RESULTS: Sensitivity and specificity of tetrofosmin SPECT for detecting coronary artery disease were 85% and 55%, respectively, in the overall population and 81% and 55% in patients without prior coronary artery bypass surgery. The overall sensitivity and specificity of tetrofosmin tomographic imaging for detection of individual coronary stenoses were 53% and 72%, respectively, in the overall population and 54% and 80% in the patients without prior coronary artery bypass surgery. CONCLUSION: One-day dipyridamole/rest 99mTc-tetrofosmin myocardial perfusion imaging is feasible and has a high sensitivity for detection of coronary artery disease.
    [Abstract] [Full Text] [Related] [New Search]